GLP1R and androgenetic alopecia: Our review highlights the promising therapeutic potential of GLP-1 receptor agonists in treating a wide range of dermatologic conditions associated with metabolic dysfunction, such as psoriasis and HS, as well as conditions with emerging links to metabolic health, such as androgenic alopecia.